Author:
Soejima Kenzo,Naoki Katsuhiko,Ishioka Kota,Nakamura Morio,Nakatani Michie,Kawada Ichiro,Watanabe Hideo,Nakachi Ichiro,Yasuda Hiroyuki,Satomi Ryosuke,Nakayama Sohei,Yoda Satoshi,Ikemura Sinnosuke,Terai Hideki,Sato Takashi,Ohgino Keiko,Arai Daisuke,Tani Tetsuo,Kuroda Aoi,Nishino Makoto,Betsuyaku Tomoko
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Siegel R, Ma J, Zou Z et al (2014) Cancer statistics (2014). CA Cancer J Clin 64(1):9–29
2. Howlader N, Noone AM, Krapcho M et al (eds) SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/ , based on November 2013 SEER data submission, posted to the SEER web site
3. Chrischilles EA, Pendergast JF, Kahn KL et al (2010) Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 28(4):620–627
4. Davidoff AJ, Tang M, Seal B et al (2010) Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 28(13):2191–2197
5. Kawaguchi T, Tamiya A, Tamura A et al (2012) Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70–74, 75–79, and 80 or older in Japan. Clin Lung Cancer 13(6):442–447
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献